Instituto de Investigación Sanitaria La Fe-ko ikertzaileekin lankidetzan egindako argitalpenak (13)

2020

  1. Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas

    Neuroendocrinology, Vol. 111, Núm. 1-2, pp. 146-157

2019

  1. Adverse effects of xenogenic scaffolding in the context of a randomized double-blind placebo-controlled study for repairing full-thickness rotator cuff tears

    Trials, Vol. 20, Núm. 1

  2. Brimonidine-induced unilateral ocular lichen planus: A case report

    Arquivos Brasileiros de Oftalmologia

  3. CX3CL1–CX3CR1 axis: A new player in coeliac disease pathogenesis

    Nutrients, Vol. 11, Núm. 11

  4. IKKα Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization

    Computational and Structural Biotechnology Journal, Vol. 17, pp. 251-262

  5. Premature aging and cancer development in transgenic mice lacking functional CYLD

    Aging, Vol. 11, Núm. 1, pp. 127-159

2016

  1. The relation of fibrosis stage with nutritional deficiencies and bioelectrical impedance analysis of body composition in patients with chronic hepatitis C

    Annals of Hepatology, Vol. 15, Núm. 4, pp. 492-500

2015

  1. Orbital nerve seath myxoma with extraocular muscle involvement: A rare case

    Seminars in Ophthalmology, Vol. 30, Núm. 4, pp. 316-320

2014

  1. Assignment of tumor subtype by genomic testing and pathologic-based approximations: Implications on patient's management and therapy selection

    Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 386-394

2013

  1. Influence of Vitamin D-Related Gene Polymorphisms (CYP27B and VDR) on the Response to Interferon/Ribavirin Therapy in Chronic Hepatitis C

    PLoS ONE, Vol. 8, Núm. 9

2012

  1. Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior

    BMC Cancer, Vol. 12

  2. Relation of IL28b gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease

    PLoS ONE, Vol. 7, Núm. 5

  3. Serum cystatin C: A non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?

    Annals of Hepatology, Vol. 11, Núm. 5, pp. 648-651